Salivary duct carcinoma (SDC) is an aggressive subtype of primary salivary gland
carcinoma, often with an advanced stage at presentation and high rates of metastasis and …

Surgical resection remains the first line treatment for salivary gland cancer (SGC). In the
case of locally advanced disease, surgery is followed by adjuvant radiotherapy. Surgical …

Treatment is complex for patients with head and neck (H&N) cancers with specific site of
disease, stage, and pathologic findings guiding treatment decision-making. Treatment …

Purpose Clinical evidence demonstrating the effectiveness of systemic therapy for advanced
salivary duct carcinoma (SDC) is lacking because of the disease's rarity. We assessed the …

Background Salivary duct carcinoma, an aggressive subtype of salivary gland cancer, is
mostly androgen receptor‐positive. Only limited data are available on androgen deprivation …

Salivary duct carcinoma (SDC) is a subtype of salivary gland cancer with a dismal prognosis
and a need for better prognostication and novel treatments. The aim of this national cohort …

Malignant Salivary Gland Tumors - StatPearls - NCBI Bookshelf US flag An official website of
the United States government Here's how you know NIH NLM Logo Access keys NCBI …

Salivary duct carcinoma (SDC) is aggressive with limited therapeutic options. A subset of
SDC display human epidermal growth factor receptor 2 (HER2) protein overexpression by …

Salivary duct carcinoma (SDC) is a rare, aggressive salivary malignancy that is often
diagnosed at an advanced stage. Previously, little was known about outcomes of this …

Background Salivary duct carcinoma (SDC) is an aggressive subtype of salivary gland
cancer. Approximately half of SDC patients will develop recurrences or metastases …